MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cadrenal Therapeutics (CVKD) Ownership - Who owns Cadrenal Therapeutics?
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more
Profile
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.03M
P/E Ratio
N/A
Total Cash
10.02M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CVKD
Capitalization
28M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
10M
Total Cash/Share
5.16
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.44M
P/B Ratio
3.77
Cash Flow
N/A
Earnings
-8.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.78K
Current Ratio
3.77
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-114.27
Shares Held By Institutions
1.09M
Shares Outstanding - Current
1.94M
Total Liabilities
2.68M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-0.276
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com